Award Timing Disclosure

12 Months Ended

Apr. 24, 2026

Mar. 10, 2026

$ / shares

Mar. 09, 2026

USD ($)

shares

$ / shares

Mar. 06, 2026

$ / shares

Award Timing Disclosures [Line Items]

Award Timing MNPI Disclosure

Equity Award Granting Practices

Equity awards for MiniMed NEOs and other employees are approved by MiniMed’s Board or the appropriate committee or sub-committee on or before the date of grant. It is MiniMed’s general practice to grant annual equity awards in July of each year. Equity awards may also be granted outside of MiniMed’s annual grant cycle for new hires, promotions, retention, or other purposes. MiniMed does not permit the timed disclosure of material non-public information for the purpose of affecting the value of executive compensation.

The following table contains information required by Item 402(x)(2) of Regulation S-K regarding stock options granted to MiniMed’s NEOs in fiscal year 2026, during the period from four business days before to one business day after the filing of MiniMed’s periodic reports on Forms 10-K and 10-Q, or current reports on Form 8-K that contained material non-public information. Specifically, the following table includes information regarding the IPO Grant Options granted to MiniMed’s NEOs on March 9, 2026, the closing date of MiniMed’s initial public offering.

Name			Grant Date			Number of securities underlying the award (#)			Exercise price of the award ($/Sh)			Grant date fair value of the award(1) ($)			Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information (2) (%)
Que Dallara			3/9/2026			252,526			$18.00			$1,868,692			(0.9)%
Chad Spooner			3/9/2026			84,176			$18.00			$622,902			(0.9)%
Ali Dianaty			3/9/2026			126,263			$18.00			$934,346			(0.9)%
Courtney Nelson Wills			3/9/2026			63,132			$18.00			$467,177			(0.9)%
Gillian Chandrasena			3/9/2026			63,132			$18.00			$467,177			(0.9)%

(1)
This column represents the grant date fair values of the IPO Grant Options, which were calculated in accordance with FASB ASC Topic 718. Information regarding the assumptions used to calculate these amounts is incorporated by reference to Note 9, “Stock-based Compensation,” to the consolidated financial statements in MiniMed’s Annual Report on Form 10-K for fiscal year 2026.

(2)
Calculated using the closing prices of MiniMed Common Stock on March 6, 2026 and March 10, 2026, of $18.49, and $18.33, per share, respectively, relating to the filing of the Form 8-K on March 9, 2026 regarding the closing of MiniMed’s initial public offering.

Award Timing Method

Equity awards for MiniMed NEOs and other employees are approved by MiniMed’s Board or the appropriate committee or sub-committee on or before the date of grant. It is MiniMed’s general practice to grant annual equity awards in July of each year. Equity awards may also be granted outside of MiniMed’s annual grant cycle for new hires, promotions, retention, or other purposes.

Award Timing Predetermined

true

Award Timing, How MNPI Considered

MiniMed does not permit the timed disclosure of material non-public information for the purpose of affecting the value of executive compensation.

MNPI Disclosure Timed for Compensation Value

false

Awards Close in Time to MNPI Disclosures, Table

The following table contains information required by Item 402(x)(2) of Regulation S-K regarding stock options granted to MiniMed’s NEOs in fiscal year 2026, during the period from four business days before to one business day after the filing of MiniMed’s periodic reports on Forms 10-K and 10-Q, or current reports on Form 8-K that contained material non-public information. Specifically, the following table includes information regarding the IPO Grant Options granted to MiniMed’s NEOs on March 9, 2026, the closing date of MiniMed’s initial public offering.

Name			Grant Date			Number of securities underlying the award (#)			Exercise price of the award ($/Sh)			Grant date fair value of the award(1) ($)			Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information (2) (%)
Que Dallara			3/9/2026			252,526			$18.00			$1,868,692			(0.9)%
Chad Spooner			3/9/2026			84,176			$18.00			$622,902			(0.9)%
Ali Dianaty			3/9/2026			126,263			$18.00			$934,346			(0.9)%
Courtney Nelson Wills			3/9/2026			63,132			$18.00			$467,177			(0.9)%
Gillian Chandrasena			3/9/2026			63,132			$18.00			$467,177			(0.9)%

(1)
This column represents the grant date fair values of the IPO Grant Options, which were calculated in accordance with FASB ASC Topic 718. Information regarding the assumptions used to calculate these amounts is incorporated by reference to Note 9, “Stock-based Compensation,” to the consolidated financial statements in MiniMed’s Annual Report on Form 10-K for fiscal year 2026.

(2)
Calculated using the closing prices of MiniMed Common Stock on March 6, 2026 and March 10, 2026, of $18.49, and $18.33, per share, respectively, relating to the filing of the Form 8-K on March 9, 2026 regarding the closing of MiniMed’s initial public offering.

Awards Close in Time to MNPI Disclosures

Share Price

$ 18.33

$ 18.49

Que Dallara [Member]

Awards Close in Time to MNPI Disclosures

Name

Que Dallara

Underlying Securities | shares

252,526

Exercise Price

$ 18

Fair Value as of Grant Date | $

$ 1,868,692

Underlying Security Market Price Change

(0.009)

Chad Spooner [Member]

Awards Close in Time to MNPI Disclosures

Name

Chad Spooner

Underlying Securities | shares

84,176

Exercise Price

$ 18

Fair Value as of Grant Date | $

$ 622,902

Underlying Security Market Price Change

(0.009)

Ali Dianaty [Member]

Awards Close in Time to MNPI Disclosures

Name

Ali Dianaty

Underlying Securities | shares

126,263

Exercise Price

$ 18

Fair Value as of Grant Date | $

$ 934,346

Underlying Security Market Price Change

(0.009)

Courtney Nelson Wills [Member]

Awards Close in Time to MNPI Disclosures

Name

Courtney Nelson Wills

Underlying Securities | shares

63,132

Exercise Price

$ 18

Fair Value as of Grant Date | $

$ 467,177

Underlying Security Market Price Change

(0.009)

Gillian Chandrasena [Member]

Awards Close in Time to MNPI Disclosures

Name

Gillian Chandrasena

Underlying Securities | shares

63,132

Exercise Price

$ 18

Fair Value as of Grant Date | $

$ 467,177

Underlying Security Market Price Change

(0.009)